| Literature DB >> 27895892 |
Emily Mackey1, Saravanan Ayyadurai2, Calvin S Pohl2, Susan D' Costa3, Yihang Li2, Adam J Moeser4.
Abstract
BACKGROUND: Biological sex plays a prominent role in the prevalence and severity of a number of important stress-related gastrointestinal and immune-related diseases including IBS and allergy/anaphylaxis. Despite the establishment of sex differences in these diseases, the underlying mechanisms contributing to sex differences remain poorly understood. The objective of this study was to define the role of biological sex on mast cells (MCs), an innate immune cell central to the pathophysiology of many GI and allergic disorders.Entities:
Keywords: Allergy; Females; Intestine; Mast cells; Sexual dimorphism; Stress
Year: 2016 PMID: 27895892 PMCID: PMC5120457 DOI: 10.1186/s13293-016-0113-7
Source DB: PubMed Journal: Biol Sex Differ ISSN: 2042-6410 Impact factor: 5.027
Fig. 1PSA-induced anaphylaxis and serum histamine levels in female and male C57BL/6 mice. a Both male and female mice showed a decrease in body temperature after injection with IgE anti-DNP antibody (10 μg/mouse, i.p.), followed 24 h later with vehicle (PBS i.p., n = 4/sex) or DNP-HSA (500 μg/mouse, i.p., n = 8/sex). Female mice exhibited a trend (p < 0.06); Two-way ANOVA on repeated measures) (p < 0.05 with individual t-tests at each time point) of lower body temperature than male mice after anaphylaxis challenge along with females demonstrating more severe peak temperature drop (b). c Over the 120-min PSA challenge, females exhibited a trend of increased clinical scores of anaphylaxis, compared to males, a difference that was statistically significant around the peak of symptoms at 60 min. d Serum levels of histamine, as measured by ELISA 30 min after DNP (values represent results from one individual experiment with n = 4 animals/sex; results were replicated in three independent experiments) showed that both male and female mice had an increase in histamine, and the increase was greater for females. e Representative photomicrographs of intestinal mesentery from male and female mice stained with toluidine blue showing increased degranulation in DNP-treated animals; original magnification, ×100, bar = 20 μM. f The number of mast cells was similar in female and male mice. Mast cells were counted in five randomly chosen fields per mouse. Values represent mean ± SE. †P < 0.10, *P < 0.05, # P < 0.0001
Fig. 2Psychological RS-induced intestinal permeability and serum histamine levels in female and male C57BL/6 mice. a After experiencing 15 min (n = 6/sex), 30 min (n = 6/male, n = 12/female), and 1 h (n = 5/sex) of restraint stress (RS), females exhibited a statistically significant increase in serum histamine (t-test; p<0.05), as measured by ELISA, compared to males. b Representative photomicrographs of intestinal mesentery from male and female mice stained with toluidine blue showing increased degranulation in RS animals; original magnification, ×20, bar = 100 μM, inset; ×100, bar = 20 μM. c Distal ileum harvested after RS demonstrated increased permeability for both females and males, compared to baseline (n = 3–4/sex). After RS, female intestinal permeability was 0.0223 ng cm2/h and male intestinal permeability was 0.0137 ng cm2/h. d Serum corticosterone increased similarly in male and female mice after 30 min RS (n = 6/male, n = 12/female). e Serum estradiol decreased in female mice after 30 min of RS (n = 6/male, n = 12/female). f Serum testosterone levels were similar in males before and after RS (n = 6). Values represent mean ± SE, *P < 0.05, **P<0.01 vs. other treatments
Fig. 3Female BMMCs release more preformed mediators in response to IgE-mediated degranulation. BMMCs were sensitized with anti-DNP IgE (1 μg/mL) overnight and later stimulated with DNP-HSA. a Male and female BMMCs were stimulated with 0, 15, 31, and 62 ng/mL of DNP-HSA for 1 h and female BMMCs exhibited elevated β-hexosaminidase release at all DNP concentrations (P < 0.05; n = 6). b Compared with male BMMCs, female BMMCs had an increased release of β-hexosaminidase after 30, 45, 60, and 90 min of DNP-HSA stimulus (62 ng/mL). c Female BMMCs released 141.9 ng/106 cells of histamine into supernatant and male BMMCs released 83.7 ng/106 cells of histamine after 1 h DNP stimulus (62 ng/mL) (P < 0.001; n = 5). d Tryptic activity from female BMMCs increased to 5.3 after degranulation, and tryptic activity from male BMMCs was 1.9 after degranulation with 1 h DNP stimulus (62 ng/mL) (P < 0.05; n = 6). e Female BMMCs released 107.4 pg of TNF-α into supernatant and male BMMCs released 25.5 pg after 1 h DNP stimulus (62 ng/mL) (P < 0.001; n = 5). All mediator release was normalized to unstimulated cells of respective sex. Values represent mean ± SE. # P = 0.10 *P < 0.05, **P<0.01 ***P < 0.001 vs. males
Fig. 4FcεRI-mediated p-tyrosine expression and Ca2+ mobilization in female and male murine BMMCs. After sensitization with anti-DNP IgE, BMMCs were stimulated with DNP-HSA (62 ng/ml) for 7 min. Results from female and male BMMCs showed no differences in a tyrosine phosphorylation of proteins after FcεRI engagement, b quantification of tyrosine-phosphorylated proteins (n = 4), or Ca2+ influx as indicated by Ca2+ tracings (c) and quantified as the d change in peak fluorescence (n = 3). Values represent mean ± SE
Fig. 5Female mast cells contain more granule-associated mediators than male mast cells. a The total tryptic activity of unstimulated female BMMCs was higher than that of male BMMCs (21.2 vs. 14.5; P < 0.01; n = 5). b The total chymase activity of unstimulated female BMMCs was higher than that of male BMMCs (9.0 vs. 6.4; P < 0.01; n = 3). c The total histamine content of unstimulated female BMMCs was higher than that of male BMMCs (827.7 vs. 487.8; P < 0.05; n = 5). d The total histamine content of female mouse pMCs was higher than that of male pMCs (35,489 vs. 22,673; P < 0.01; n = 7/male, n = 11/female). e The total histamine content of pMCs from female rats was higher than that of male rat pMCs (71,806 vs. 43,167; P < 0.001 n = 3). f Representative images of peritoneal mast cells recovered and pooled from five, 8-week-old male and female C57BL/6 mice and analyzed by TEM. Scale bar = 2 μm. All values were normalized to cell number. Values represent mean ± SE. *P < 0.05, **P < 0.01, ***P < 0.001 vs. males
Fig. 6A23187-induced degranulation and Ca2+ mobilization in female and male murine BMMCs. BMMCs were stimulated for 1 h with the Ca2+ ionophore, A23187 (1 μM). a BMMCs from females showed a 50.6% increase in β-hexosaminidase release and male BMMCs showed a 39.9% increase, a difference that was significant (P < 0.001; n = 6). b Female BMMCs released 406.1 ng/106 cells of histamine into supernatant and male BMMCs released 159.3 ng/106 cells of histamine (P < 0.001; n = 5). c Tryptic activity (ΔOD405/min/106 cells) from female BMMCs increased to 7.6 after degranulation, and tryptic activity from male BMMCs was 3.2 after degranulation (P < 0.001; n = 4). d Female BMMCs released 165.7 pg of TNF-α into supernatant and male BMMCs released 103.4 pg (P < 0.01; n = 4). All mediator release was normalized to unstimulated cells of respective sex. e Female and male BMMCs exhibited similar Ca2+ influx as measured by e Ca2+ tracings and quantified as the f change in peak fluorescence after stimulation with A23187 (1 μM). Values represent mean ± SE. **P < 0.01, ***P < 0.001 vs. males
Fig. 7Influence of the estrous cycle on serum histamine response and tissue MC histamine content and number. a After experiencing 30 min of RS, serum histamine levels were similar between female mice in all stages of the estrous cycle. b The total histamine content of mouse female pMCs was similar at each stage of the estrous cycle. c During proestrus and estrus, female mice had higher numbers of pMCs than male mice. Values represent mean ± SE. *P < 0.05 vs. males
Fig. 8Sexually dimorphic gene expression in BMMCs from C57BL/6 mice. a A total of 8233 genes were found to be differentially expressed between 6-week-old male and female BMMCs using RNA-sequencing technology (Illumina HiSeq 2500) (n = 3). b There were many genes that code for proteins involved in cellular processes and metabolic processes that were upregulated in females compared to males
Expression of genes in female BMMCs relative to male BMMCs, involved in forming immune mediators stored in mast cell granules
| Gene name | Gene symbol | Comments | Statistics | |
|---|---|---|---|---|
| Log2 fold change |
| |||
| Tumor necrosis factor |
| Proinflammatory cytokine stored in preformed mast cell granules (Gordon & Galli 1990 [ | 3.48 | 0.00016 |
| Mast cell protease 1 |
| B-chymase involved in maintaining granule structure (Wastling 1998 [ | 2.70 | 0.015 |
| Mast cell protease 2 |
| Enzymatically inactive chymase without known function (Caughley 2011 [ | 0.64 | 0.00016 |
| Mast cell protease 4 |
| Functional equivalent to human mast cell chymase (Caughley 2015 [ | 0.39 | 0.037 |
| Mast cell protease 8 |
| Serine protease more closely related to granzymes and cathepsin G than chymases (Lutzelschwab 1998 [ | 1.71 | 0.00016 |
| Tryptase beta 2 |
| Serine protease important for pathology in a variety of inflammatory conditions (Payne 2004 [ | −1.35 | 0.00016 |
| Cathepsin B |
| Cysteine protease that processes protryptase to mature tryptase (Le 2011a [ | 0.31 | 0.015 |
| Cathepsin C |
| Cysteine protease that is an upstream activator of tryptases, chymases, and cathepsin G (Caughley 2015 [ | 0.99 | 0.00016 |
| Cathepsin G |
| Serine protease with tryptic and chymotryptic activity (Caughley 2007 [ | 1.16 | 0.00016 |
| Cathepsin H |
| Cysteine protease that may be involved in tumor progression (Schweiger 2004 [ | 1.28 | 0.0099 |
| Cathepsin K |
| Cysteine protease that degrades type 1 collagen (Bone 2004 [ | 1.71 | 0.00016 |
| Cathepsin L |
| Cysteine protease that processes protryptase to mature tryptase (Le 2011a [ | 1.09 | 0.00016 |
| Cathepsin S |
| Cysteine protease linked to inflammatory processes such as atherosclerosis, asthma, and atopic dermatitis [ | 1.28 | 0.00016 |
| Cathepsin Z |
| Cysteine protease involved in enhanced metastasis in various cancers (Wang 2011 [ | 1.02 | 0.00016 |
| Cathepsin E |
| Aspartic protease that processes procarboxypeptidase (Henningsson 2005 [ | −2.05 | 0.00016 |
| Cathepsin F |
| Cysteine protease most notably found in neural tissue (Tang 2006 [ | −2.46 | 0.00016 |
| Cathepsin O |
| Cysteine protease with endoprotease activity (Zhang 2015 [ | −1.09 | 0.00016 |
| B-hexosaminidase subunit alpha |
| Alpha subunit of the lysosomal hydrolase B-hexosaminidase, an important enzyme in defense against pathogens (Fukuishi 2014 [ | 0.32 | 0.0038 |
| Phosphoribosyl pyrophosphate synthetase 1 |
| Key enzyme involved in histidine and tryptophan synthesis [ | 2.45 | 0.00016 |
| Phosphoribosyl pyrophosphate synthetase 2 |
| Key enzyme involved in histidine and tryptophan synthesis [ | 0.54 | 0.00074 |
| Tryptophan hydroxylase 1 |
| Key enzyme in the synthesis of serotonin from tryptophan (Nowak 2012 [ | 0.55 | 0.0011 |
Q values <0.05 are considered significant
Expression of genes in female BMMCs relative to male BMMCs, involving granule biogenesis and maturation
| Gene name | Gene symbol | Comments | Statistics | |
|---|---|---|---|---|
| Log2 fold change |
| |||
| Spermidine synthetase |
| Synthesizes polyamines important in granule biogenesis and homeostasis, including storage of histamine and proteases (Garcia-Faroldi, 2010 [ | 3.68 | 0.00016 |
| Ornithine decarboxylase 1 |
| Synthesizes polyamines important in granule biogenesis and homeostasis, including storage of histamine and proteases (Garcia-Faroldi, 2010 [ | 2.52 | 0.00016 |
| Spermine synthetase |
| Synthesizes polyamines important in granule biogenesis and homesostasis, including storage of histamine and proteases (Garcia-Faroldi, 2010 [ | 0.54 | 0.0045 |
| Basic helix-loop-helix family, member A15 |
| Important transcription factor in forming mature secretory granules in a variety of specialized secretory cells (Tian 2010 [ | 3.42 | 0.00016 |
| Rab5c, member of Ras oncogene family |
| Key regulator of mast cell granule fusion during biogenesis (Azouz 2014 [ | 0.62 | 0.00032 |
| Mannose-6-phosphate receptor |
| Transports glycosylated proteins, such as lysosomal hydrolases and TNF, into vesicles (Coutinho 2012 [ | 0.43 | 0.00016 |
| Adaptor protein 1A complex |
| Protein necessary for the sorting of proteins into vesicles and secretory granule maturation (Bonnemaison 2014 [ | 0.36 | 0.0033 |
| ATPase, H+ transporting, lysosomal 16 kDa, V0 subunit c |
| Component of a vacuolar type H+ ATPase that acidifies granule lumen for condensation of granule contents (Borges 2011) | 0.69 | 0.00016 |
| ATPase, H+ transporting, lysosomal 50/57 kDa, V1 subunit H |
| Component of a vacuolar type H+ ATPase that acidifies granule lumen for condensation of granule contents (Borges 2011) | 0.52 | 0.00016 |
| ATPase, H+ transporting, lysosomal V0 subunit a2 |
| Component of a vacuolar type H+ ATPase that acidifies granule lumen for condensation of granule contents (Borges 2011) | 0.46 | 0.00016 |
| ATPase, H+ transporting, lysosomal 50/57 kDa, V1 subunit H |
| Component of a vacuolar type H+ ATPase that acidifies granule lumen for condensation of granule contents (Borges 2011) | 0.42 | 0.020 |
| ATPase, H+ transporting, lysosomal 9 kDa, V0 subunit e1 |
| Component of a vacuolar type H+ ATPase that acidifies granule lumen for condensation of granule contents (Borges 2011) | 0.32 | 0.0044 |
| ATPase, H+ transporting, lysosomal 34 kDa, V1 subunit D |
| Component of a vacuolar type H+ ATPase that acidifies granule lumen for condensation of granule contents (Borges 2011) | −0.24 | 0.038 |
| ATPase, H+ transporting, lysosomal 13 kDa, V1 subunit G2 |
| Component of a vacuolar type H+ ATPase that acidifies granule lumen for condensation of granule contents (Borges 2011) | −1.84 | 0.00016 |
| Lysosomal trafficking regulator |
| Important regulator of granule formation (Durchfort 2012 [ | −1.29 | 0.00016 |
| Solute carrier family 18, member 2 | Slc18a2 | Transports histamine and serotonin into granules (Merickel 1995 [ | −0.92 | 0.00016 |